Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CRISPR01:59

CRISPR

57.3K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.3K
What is Genetic Engineering?00:49

What is Genetic Engineering?

79.4K
Overview
79.4K
Meiosis I03:09

Meiosis I

43.6K
Meiosis is the division of a diploid cell into haploid cells forming sperm and eggs in animals through differentiation. Meiosis I is the first stage of meiosis, where the genetic recombination of homologous chromosomes and the reduction of the ploidy level by half occurs.
Prophase I is the most extended and complex step of meiosis I characterized by synapsis, chromosome pairing, and recombination of the homologous chromosomes. This process is facilitated by a proteinaceous structure called the...
43.6K
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

8.9K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
8.9K
Homologous Recombination02:31

Homologous Recombination

62.1K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
62.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fertility planning for women in medicine: a call for an active approach.

International journal of women's dermatology·2026
Same author

Prenatal Diagnosis and Novel Therapeutics in Treatment of Genetic Conditions: Challenges and Opportunities.

Clinical therapeutics·2026
Same author

Uterine transposition: five live births and counting.

F&S reports·2026
Same author

Holding Space and Time for Difference.

Narrative inquiry in bioethics·2026
Same author

Timing Matters? Impact of Early Sperm Processing on Motile Sperm Recovery, Fertilization, Blastocyst Rate, and Pregnancy Outcomes in IUI and IVF.

Journal of clinical medicine·2025
Same author

The Challenges of Reproductive Autonomy in an Unjust System.

The American journal of bioethics : AJOB·2025

Related Experiment Video

Updated: Jan 1, 2026

Screening Sperm for the Rapid Isolation of Germline Edits in Zebrafish
05:55

Screening Sperm for the Rapid Isolation of Germline Edits in Zebrafish

Published on: February 10, 2023

1.6K

Prioritizing Women's Health in Germline Editing Research.

Ruth M Farrell1, Marsha Michie2, Christopher T Scott3

  • 1A staff physician and the vice chair of research of the OB/GYN and Women's Health Institute at the Cleveland Clinic, in Cleveland, Ohio, where she is also on the staff of the Center for Bioethics.

AMA Journal of Ethics
|December 27, 2019
PubMed
Summary

Women

More Related Videos

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors
09:22

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

5.9K
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

2.7K

Related Experiment Videos

Last Updated: Jan 1, 2026

Screening Sperm for the Rapid Isolation of Germline Edits in Zebrafish
05:55

Screening Sperm for the Rapid Isolation of Germline Edits in Zebrafish

Published on: February 10, 2023

1.6K
Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors
09:22

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

5.9K
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

2.7K

Area of Science:

  • Biomedical Ethics
  • Genetics
  • Reproductive Technologies

Background:

  • Germline editing discussions have overlooked women's health and well-being as patients and research subjects.
  • Past restrictions on uterine transfer of modified human embryos limited research scope.
  • The boundary of uterine transfer has been crossed, necessitating a re-evaluation of ethical considerations.

Purpose of the Study:

  • To highlight the underrepresentation of women's interests in germline editing debates.
  • To address the ethical implications of women's health risks in germline modification research.
  • To emphasize the need for safeguards for women participating in these studies.

Main Methods:

  • Literature review of ethical discussions on germline editing.
  • Analysis of the impact of reproductive technology advancements on women's health.
  • Ethical framework analysis concerning patient and subject welfare.

Main Results:

  • Women's perspectives as patients and subjects are significantly absent in current germline editing discourse.
  • The crossing of the uterine transfer boundary exacerbates risks for women in research.
  • Inadequate safeguards exist for women undergoing germline modification research.

Conclusions:

  • Urgent ethical discussions are needed to include women's health and safety in germline editing research.
  • Policy and guidelines must be developed to protect women from disproportionate risks.
  • Ensuring equitable benefits and mitigating risks for women is crucial for responsible innovation in genome editing.